Russell Investments Group, Ltd. Biomarin Pharmaceutical Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 45,522 shares of BMRN stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,522

Previous 57,520 20.86%

Holding current value

$2.99 Million

Previous $4.74 Million 32.44%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $828,101 - $1.13 Million	-11,998 Reduced 20.86%	45,522 $3.2 Million
Q2 2024 Aug 08, 2024	SELL	$74.43 - $92.22 $543,785 - $673,759	-7,306 Reduced 11.27%	57,520 $4.74 Million
Q1 2024 May 08, 2024	BUY	$83.81 - $99.0 $1.96 Million - $2.32 Million	23,414 Added 56.54%	64,826 $5.66 Million
Q4 2023 Feb 05, 2024	BUY	$76.22 - $98.51 $97,256 - $125,698	1,276 Added 3.18%	41,412 $3.99 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $7.35 Million - $8.17 Million	-86,429 Reduced 68.29%	40,136 $3.55 Million
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $11 Million - $12.7 Million	-126,747 Reduced 50.04%	126,565 $11 Million
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $3.75 Million - $5.02 Million	-42,790 Reduced 14.45%	253,312 $24.6 Million
Q4 2022 Feb 08, 2023	BUY	$80.93 - $108.63 $4.12 Million - $5.53 Million	50,879 Added 20.75%	296,102 $30.6 Million
Q3 2022 Nov 04, 2022	BUY	$82.16 - $96.94 $12.7 Million - $15 Million	154,900 Added 171.5%	245,223 $20.8 Million
Q2 2022 Jul 29, 2022	BUY	$71.48 - $86.85 $3.97 Million - $4.82 Million	55,505 Added 159.41%	90,323 $7.51 Million
Q1 2022 May 05, 2022	SELL	$74.28 - $92.69 $351,195 - $438,238	-4,728 Reduced 11.96%	34,818 $2.7 Million
Q4 2021 Jan 21, 2022	SELL	$71.72 - $91.47 $802,833 - $1.02 Million	-11,194 Reduced 22.06%	39,546 $3.51 Million
Q3 2021 Nov 08, 2021	BUY	$74.77 - $85.47 $996,833 - $1.14 Million	13,332 Added 35.64%	50,740 $3.91 Million
Q2 2021 Aug 04, 2021	BUY	$75.51 - $84.79 $570,478 - $640,588	7,555 Added 25.31%	37,408 $3.12 Million
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $1.97 Million - $2.39 Million	-26,362 Reduced 46.89%	29,853 $2.25 Million
Q4 2020 Feb 08, 2021	SELL	$72.61 - $90.2 $169,399 - $210,436	-2,333 Reduced 3.98%	56,215 $4.92 Million
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $1.34 Million - $2.44 Million	-18,630 Reduced 24.14%	58,548 $4.45 Million
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $4.72 Million - $7.37 Million	59,355 Added 333.02%	77,178 $9.5 Million
Q1 2020 May 06, 2020	SELL	$71.37 - $96.85 $39,967 - $54,236	-560 Reduced 3.05%	17,823 $1.48 Million
Q3 2019 Nov 01, 2019	SELL	$67.4 - $85.11 $1.93 Million - $2.44 Million	-28,705 Reduced 60.96%	18,383 $1.25 Million
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $709,088 - $828,667	8,825 Added 23.06%	47,088 $4.01 Million
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $1.06 Million - $1.25 Million	12,628 Added 49.26%	38,263 $3.39 Million
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $480,920 - $636,526	-6,001 Reduced 18.97%	25,635 $2.16 Million
Q3 2018 Oct 26, 2018	SELL	$93.92 - $105.72 $1.08 Million - $1.21 Million	-11,466 Reduced 26.6%	31,636 $3.08 Million
Q2 2018 Aug 08, 2018	BUY	$76.01 - $99.03 $808,290 - $1.05 Million	10,634 Added 32.75%	43,102 $4.03 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $5.85 Million - $6.98 Million	-75,362 Reduced 69.89%	32,468 $2.63 Million
Q4 2017 Feb 06, 2018	SELL	$80.76 - $95.13 $9.62 Million - $11.3 Million	-119,061 Reduced 52.47%	107,830 $9.76 Million
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $18.3 Million - $21.5 Million	226,891	226,891 $21.1 Million

Others Institutions Holding BMRN

# of Institutions

629

Shares Held

178M

Call Options Held

1.98M

Put Options Held

1.17M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Biomarin Pharmaceutical Inc Transaction History